Approved · ActiveModality: Liposomal injectable suspension (pMVL drug delivery technology)
Partnerships LG Chem (Jan 2026): exclusive rights to commercialize EXPAREL in select Asia-Pacific markets; Pacira manufactures. Marketing authorization filed in South Korea and Thailand.
Indications
Postsurgical local analgesia via infiltration (patients 6+ years)(Approved)
Status note Commercialized in the US since Apr 2012; approved in select European countries and the UK (Nov 2021). Pediatric study commitments ongoing; FDA/EMA waived pediatric requirements for nerve-block indications.
Partnerships J&J MedTech (Jul 2025): exclusive third-party co-promoter for ZILRETTA in the US (initial term through 2031); Johnson & Johnson MedTech sales force extends reach beyond orthopedics. Acquired via Flexion Therapeutics (Nov 2021; contingent milestones through Dec 2030)
Indications
Osteoarthritis knee pain(Approved)
Status note First and only extended-release intra-articular injection indicated for OA knee pain.
Partnerships Baylor College of Medicine: exclusive worldwide license to underlying PCRX-201 patents. Acquired via Flexion (Nov 2021); company holds a stake in GQ Bio (HCAd platform).
Indications
Osteoarthritis knee pain(Phase 2)
Status note Locally administered gene therapy for OA knee pain. FDA RMAT designation Feb 2024. Lead program from proprietary high-capacity adenovirus (HCAd) vector platform.
PCRX-2002
Phase 2 · ActiveModality: Long-acting formulation
Indications
Postsurgical pain(Phase 2)
Status note Complementary long-acting formulation of the non-opioid analgesic ropivacaine for postsurgical pain control.
Per-asset detail extracted from the 10-Q filed 2026-08-04. Fields the filing does not state are marked "not disclosed" rather than filled from other sources.
Sponsor-matched active trials from ClinicalTrials.gov (0 as sponsor, 1 as collaborator); "Sponsor" = company is the lead sponsor, "Collaborator" = company is a collaborator. The BP column flags big-pharma involvement as lead sponsor or collaborator (excluding the company itself). The Mgmt guide column shows what management guided for readout timing when a guided program matches the trial (hover for the quote, click for the source). Trial listings are not a company pipeline slide.